Fig. 1From: Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticlesSchematic illustration of the preparation of HMMDN-Met@PM and the treatment for tumorBack to article page